Tildrakizumab

Definition: Tildrakizumab, sold under the brand name Ilumya among others, is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. It is approved for the treatment of adults with moderate-to-severe plaque psoriasis in the United States and in the European Union. source: Wikipedia

ID

771591006

ID date

8 Sep 2021

Previous ID

35906611000001103

Name

Tildrakizumab